General Info
CRISPR Therapeutics is focused on the development of transformative medicines using its proprietary CRISPR/Cas9 gene-editing platform.
Location: Cambridge
Country:
Industries:
Investment Regions:
Investment Stages: seed, series-a
Website: http://crisprtx.com/
Want to start building warm intros with this investor?
🤖 AI Activity Report
Status: not-active
AI Reasoning: Search of CRISPR Therapeutics press releases and investor relations showed company announcements through 2025 focused on clinical updates, financings as issuer (registered direct offerings) and collaborations, but no press release indicating CRISPR Therapeutics made an investment into an external startup. The most recent financing activity where CRISPR was a participant is not found as an investor in a startup; no evidence of an outbound investment in past 12 months. Therefore classify as not-active. No specific startup investment found within past years.
Here are the thresholds established for the different statuses:
Not Active – No known investments in the last 12 months.
Low Activity – Only known investments between the last 12 and 6 months.
Active – Known investments between the last 6 and 3 months.
Very Active – Known investments in the last 3 months.
Investor Contact
Team Members
Name
Role
Email
LinkedIn
…
…
…
…
…
Investment Regions Map
loading map…
Similar Investors
Other similar investors:
Latest on X (Twitter)
Access all contact details of CRISPR Therapeutics
Gain instant access to partner names, verified emails, LinkedIn profiles, and more—all in one place. Dive into their portfolio founders and their LinkedIn information, so you can quickly start your outreach and look for warm intros.
Add custom tags to your investor cards. Label them by investment stage, industry focus, interest level, or any other criteria you want to stay organized.
Trusted by Founders like You
Find your matching investors using AI